PSOMAGEN INC

PSOMAGEN INC specializes in advanced molecular diagnostics and high-throughput proteomic and genomic analysis for biomedical research, with deep expertise in OLINK proteomics, next-generation sequencing, and transcriptome profiling. The company delivers precision laboratory services for complex disease research, including sickle cell disease and sepsis, utilizing cutting-edge platforms for plasma protein quantification, genotyping, microarray analysis, and long-read sequencing. Their technical capabilities span biomarker discovery, variant characterization of TTR and other genetic modifiers, and NGS-based sample processing for hematologic and immunologic studies, positioning them as a trusted provider of sensitive, scalable analytical workflows for translational research. The contractor maintains a strong, sustained relationship with the Department of Health and Human Services, particularly within NIH’s NHLBI and Sickle Cell Branch, where they support critical proteomic and genomic studies of rare blood disorders. They also deliver biotechnology research services to the Department of Agriculture, primarily through Sanger sequencing and related genomic analyses, indicating adaptability across human and agricultural health domains. Their primary industry focus lies in testing laboratories and services (NAICS 541380), where they operate as a specialized contract research organization for high-complexity clinical and research samples, complemented by active work in biotechnology R&D (541714) and medical laboratories (621511). This positions them at the intersection of academic research and federal biomedical programs requiring rigorous, reproducible data generation. PSOMAGEN INC is a small business headquartered in Rockville, Maryland, with no federal certifications on record. Their geographic proximity to NIH and other federal research hubs enhances their responsiveness to time-sensitive federal projects, reinforcing their role as a niche provider of advanced genomic and proteomic services within the U.S. government life sciences ecosystem.